Kyowa Kirin (KYKOF) News Today $14.97 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell TherapiesDecember 9, 2024 | businesswire.comAnalysts supportive of Kura/Kirin deal despite major selloff (update)November 21, 2024 | seekingalpha.comKura Oncology Shares Fall 14% on Plans for Cancer-Drug CollaborationNovember 20, 2024 | marketwatch.comKura Oncology, Kyowa Kirin to develop and commercialize ziftomenib in leukemiasNovember 20, 2024 | markets.businessinsider.comKura Oncology Partners With Kyowa Kirin To Develop Ziftomenib For Acute Leukemias; Stock DropsNovember 20, 2024 | markets.businessinsider.comKura Oncology to partner with Kyowa Kirin for blood cancer therapyNovember 20, 2024 | reuters.comKyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical CompanyOctober 31, 2024 | businesswire.comKyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024October 8, 2024 | businesswire.comKyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic DermatitisSeptember 25, 2024 | prnewswire.comKyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual MeetingSeptember 19, 2024 | prnewswire.comA Promising Pipeline Ready to Break out at BridgeBio Pharma (BBIO)September 8, 2024 | msn.comKyowa Kirin Co., Ltd. (KYKOF)August 30, 2024 | sg.finance.yahoo.comKyowa Kirin to end distribution of Fareston (toremefine) in the United StatesAugust 23, 2024 | prnewswire.comKyowa Kirin Co., Ltd. (KYKOY)August 21, 2024 | uk.finance.yahoo.comKyowa Kirin Non-GAAP EPS of ¥70.75, revenue of ¥232.9BAugust 3, 2024 | msn.comJapan Drugmaker Kyowa Kirin Sells China Unit for $100 MillionAugust 1, 2024 | bloomberg.comKyowa Kirin Co. Ltd.July 25, 2024 | wsj.comNQASPA30LMT:IND NASDAQ ASPA Financials Large Mid Cap TR IndexJuly 25, 2024 | seekingalpha.comKyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NCJune 10, 2024 | prnewswire.comKyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024May 8, 2024 | prnewswire.comKYKOY Kyowa Kirin Co., Ltd.April 19, 2024 | seekingalpha.comKyowa Kirin Co Ltd (KY4.SG)April 16, 2024 | finance.yahoo.comKyowa Kirin: First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary SyndromeApril 15, 2024 | finanznachrichten.deFirst Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary SyndromeApril 15, 2024 | finance.yahoo.comKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On TherapiesApril 12, 2024 | finance.yahoo.comKyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On TherapiesApril 12, 2024 | prnewswire.comKyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024April 2, 2024 | prnewswire.comKYKOF Kyowa Kirin Co., Ltd.March 26, 2024 | seekingalpha.comBreaking Down the $4.3 Million Price Tag Kyowa Kirin’s Gene Therapy for Rare Genetic DiseaseMarch 21, 2024 | msn.comKyowa Kirin's gene therapy most expensive US drug with $4.3 million price tagMarch 20, 2024 | msn.comKyowa Kirin's gene therapy most expensive US drug with $4.3 mln price tagMarch 20, 2024 | reuters.comKyowa buyout Orchard wins FDA nod for rare disease therapyMarch 19, 2024 | msn.comPharma exec talks construction, hiring for new North Carolina plantMarch 18, 2024 | bizjournals.comHow NC city lured Japanese pharma Kyowa Kirin's $200M investmentMarch 8, 2024 | bizjournals.comKyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024March 8, 2024 | finance.yahoo.comHow a North Carolina city lured Japanese pharma's $200M investmentMarch 6, 2024 | bizjournals.comKyowa Kirin to set up a new plant in Sanford, USAFebruary 28, 2024 | msn.comRock Hill misses out on $200M project from Japanese pharmaceutical company Kyowa KirinFebruary 27, 2024 | bizjournals.comKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 MeetingFebruary 14, 2024 | finance.yahoo.comKyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 MeetingFebruary 14, 2024 | prnewswire.comBridgeBio grants Japanese rights to Kyowa Kirin for dwarfism drugFebruary 7, 2024 | msn.comBridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in JapanFebruary 7, 2024 | finance.yahoo.comKyowa Kirin Announces First Patient Enrolled in the Phase 2 Clinical Trial Evaluating Tivozanib Eye Drops in Patients with Diabetic Macular EdemaFebruary 6, 2024 | finance.yahoo.comBoehringer Ingelheim, Kyowa Kirin enter license agreement to develop novel treatment for fibro-inflammatory diseasesJanuary 8, 2024 | msn.comKyowa Kirin Co LtdDecember 14, 2023 | morningstar.comKyowa Kirin Co Ltd ADR KYKOYNovember 8, 2023 | morningstar.comKyowa Kirin reports 9M resultsNovember 1, 2023 | msn.comKyowa Kirin Presents Real-World Findings at ASBMR Annual Meeting Highlighting Progressive Disease Burden of X-linked Hypophosphatemia (XLH)October 16, 2023 | finance.yahoo.comKyowa Kirin to Present New Research on X-linked Hypophosphatemia (XLH) at ASBMR Annual MeetingOctober 12, 2023 | finance.yahoo.comKyowa Kirin Announces Three Abstracts and A Symposium at the European Academy of Dermatology and Venereology Congress 2023October 11, 2023 | finance.yahoo.com Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… KYKOF Media Mentions By Week KYKOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KYKOF News Sentiment▼0.720.60▲Average Medical News Sentiment KYKOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KYKOF Articles This Week▼00▲KYKOF Articles Average Week Get Kyowa Kirin News Delivered to You Automatically Sign up to receive the latest news and ratings for KYKOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Daiichi Sankyo News Today JCR Pharmaceuticals News Today Mayne Pharma Group News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Scilex News Today Virbac News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:KYKOF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyowa Kirin Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyowa Kirin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
